Xunlei Ltd: Form 20-F for the period ended Dec 31, 2022
Filed with the SEC on Apr 26, 2023 and accepted by EDGAR at Apr 26, 2023, 08:14 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $341.5m | us-gaap:Revenues |
| Cost of revenue | 12 months2022-01-01 to 2022-12-31 | $200.1m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2022-01-01 to 2022-12-31 | $141.4m | us-gaap:GrossProfit |
| Research and development | 12 months2022-01-01 to 2022-12-31 | $67.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | $10.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $4.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | $21.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | $0.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | $0.06 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 336,235,501 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | $51.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $15.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $177.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $332.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $463.3m | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $128.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $154.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-12-31 | $309.9m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-12-31 | 325,047,736 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001410578-23-000797. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.